Find disease awareness content and relevant supporting materials

Objective: To determine whether tocilizumab (TCZ) improves outcomes of patients hospitalized with moderate-to-severe COVID-19 pneumonia.

Patients admitted to intensive care are often haemodynamically unstable with fluid resuscitation therapy regularly used to overcome this.

We propose an integrated and adaptable approach to improve patient care and clinical outcomes through analgesia and light sedation, initiated early during an episode of critical illness and as a priority of care.

Acute kidney injury (AKI) affects one-fifth of major surgery patients, increasing the risk of long-term mortality. This review paper discusses recent study data, discussing the best methods for preventing postoperative AKI.

This review is a Pro-Con discussion about the optimal fluid volume in critically ill patients in the intensive care unit (ICU).

In 2007, the Saline versus Albumin Fluid Evaluation-Translation of Research Into Practice Study (SAFE-TRIPS) reported that...

European Commission has granted Dexdor (dexmedetomidine) from Orion, centralised approval covering 27 European Union countries for sedation of adult intensive...

Top-line results of the TRA-2P study of vorapaxar, from Merck, showed that the addition of vorapaxar to standard of care...

Boston Scientific Corporation announced FDA 510(k) clearance of the EXALT Model B Single-Use Bronchoscope, designed for use in bedside procedures within the intensive care unit (ICU) and operating room (OR).

Liver failure can occur in patients with or without underlying chronic liver disease (mainly cirrhosis) and is, respectively, termed acute on chronic liver failure or acute liver failure (ALF). In both cases, it is associated with...